Literature DB >> 16353942

In vivo microdialysis for PK and PD studies of anticancer drugs.

Qingyu Zhou1, James M Gallo.   

Abstract

In vivo microdialysis technique has become one of the major tools to sample endogenous and exogenous substances in extracellular spaces. As a well-validated sampling technique, microdialysis has been frequently employed for quantifying drug disposition at the desired target in both preclinical and clinical settings. This review addresses general methodological considerations critical to performing microdialysis in tumors, highlights selected preclinical and clinical studies that characterized drug disposition in tumors by the use of microdialysis, and illustrates the potential application of microdialysis in the assessment of tumor response to cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353942      PMCID: PMC2751268          DOI: 10.1208/aapsj070366

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  66 in total

1.  Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors.

Authors:  D Artemov; M Solaiyappan; Z M Bhujwalla
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

2.  Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma.

Authors:  C Joukhadar; N Klein; R M Mader; C Schrolnberger; B Rizovski; E Heere-Ress; H Pehamberger; N Strauchmann; B Jansen; M Müller
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

Review 3.  Delivery of molecular and cellular medicine to solid tumors.

Authors:  R K Jain
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

4.  Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer.

Authors:  K J Harrington; C R Lewanski; A D Northcote; J Whittaker; H Wellbank; R G Vile; A M Peters; J S Stewart
Journal:  Ann Oncol       Date:  2001-04       Impact factor: 32.976

5.  Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.

Authors:  J Ma; S Pulfer; S Li; J Chu; K Reed; J M Gallo
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

6.  Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.

Authors:  Y Tokunaga; M Nakashima; H Sasaki; N Tomiyama; M N Nakashima; M Ichikawa; M Kaminogo; S Shibata
Journal:  Biol Pharm Bull       Date:  2000-12       Impact factor: 2.233

7.  Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis.

Authors:  F Sjögren; C Svensson; C Anderson
Journal:  Br J Dermatol       Date:  2002-03       Impact factor: 9.302

Review 8.  Microdialysis: an in vivo approach for measuring drug delivery in oncology.

Authors:  Martin Brunner; Markus Müller
Journal:  Eur J Clin Pharmacol       Date:  2002-05-23       Impact factor: 2.953

9.  Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.

Authors:  S R Meikle; J C Matthews; C S Brock; P Wells; R J Harte; V J Cunningham; T Jones; P Price
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

10.  In vitro and in vivo microdialysis calibration using retrodialysis for the study of the cerebrospinal distribution of bupivacaine.

Authors:  R Clément; J M Malinovsky; G Dollo; P Le Corre; F Chevanne; R Le Verge
Journal:  J Pharm Biomed Anal       Date:  1998-08       Impact factor: 3.935

View more
  19 in total

1.  A HPLC method for the quantitative determination of N-(2-hydroxy-5-nitrophenylcarbamothioyl)-3,5-dimethylbenzamide in biological samples.

Authors:  Igor Skidan; Jacob Grunwald; Ritesh Thekkedath; Alexei Degterev; Vladimir Torchilin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-04-06       Impact factor: 3.205

2.  Influence of blood-brain barrier efflux pumps on the distribution of vincristine in brain and brain tumors.

Authors:  Fan Wang; Feng Zhou; Gary D Kruh; James M Gallo
Journal:  Neuro Oncol       Date:  2010-05-25       Impact factor: 12.300

3.  Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems.

Authors:  Sameed Ahmed; Miandra Ellis; Hongshan Li; Luca Pallucchini; Andrew M Stein
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-29       Impact factor: 2.745

4.  A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent.

Authors:  Jana Portnow; Behnam Badie; Xueli Liu; Paul Frankel; Shu Mi; Mike Chen; Timothy W Synold
Journal:  J Neurooncol       Date:  2014-03-15       Impact factor: 4.130

Review 5.  A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.

Authors:  Chun Min Kho; Siti Kartini Enche Ab Rahim; Zainal Arifin Ahmad; Norazharuddin Shah Abdullah
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

6.  Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.

Authors:  Shana Jacobs; Cynthia L McCully; Robert F Murphy; John Bacher; Frank M Balis; Elizabeth Fox
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-07       Impact factor: 3.333

7.  A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.

Authors:  Jana Portnow; Behnam Badie; Susan Markel; An Liu; Massimo D'Apuzzo; Paul Frankel; Rahul Jandial; Timothy W Synold
Journal:  Eur J Cancer       Date:  2013-02-04       Impact factor: 9.162

8.  Interstitial fluid: the overlooked component of the tumor microenvironment?

Authors:  Helge Wiig; Olav Tenstad; Per Ole Iversen; Raghu Kalluri; Rolf Bjerkvig
Journal:  Fibrogenesis Tissue Repair       Date:  2010-07-23

9.  The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.

Authors:  Jana Portnow; Behnam Badie; Mike Chen; An Liu; Suzette Blanchard; Timothy W Synold
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

Review 10.  Micelles and nanoparticles for ultrasonic drug and gene delivery.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  Adv Drug Deliv Rev       Date:  2008-04-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.